Skip to content

A clinical trial to study the effectiveness of fully immersive virtual reality and cognitive training on global cognition,quality of life,iadls and brain activities in patients with mild to moderate Alzheimers disease

Efficacy of Immersive Virtual Reality and Cognitive Training on various parameters in patients suffering from Alzheimers Disease:A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065623
Enrollment
100
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G300- Alzheimers disease with early onset

Interventions

Intervention1: Immersive Virtual Reality : Full immersion VR environment will be created for the participants with the help of head mounted device(HMD) which will consists of games involving multidom

Sponsors

Reena Kumari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients older than 60 years with diagnosis of AD, consent in participation,absence of vision and hearing impairment likely to effect social life,ability to read and write

Exclusion criteria

Exclusion criteria: 1)Patients who have major neurological or psychiatric conditions that may affect cognition (e.g., Parkinson’s disease, Stroke, Schizophrenia) 2)Patients who are unable to comply with the training regimen 3)Patients with visual, vestibular, and auditory impairments 4)Severe orthopaedic impairments

Design outcomes

Primary

MeasureTime frame
Global cognitive function measured using montral cognitive scale Brain activities measured using Electroencephalogram (EEG) Timepoint: at baseline and after 8 weeks

Secondary

MeasureTime frame
Activities of Daily Living measured by Instrumental activities of daily living scale (IADLS) Quality of Life measured by Quality of Life in Alzheimer’s Disease Timepoint: at baseline and after 8 weeks

Countries

India

Contacts

Public ContactDr Jaspreet Kaur

Guru Jambheshwar University of Science and Technology,Hisar,Haryana

jaspreet248103@gmail.com9466092657

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026